Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 6, 2012, Pages 1389-1394

  Hohmann, Joachim ^a   Newerla, Caroline ^a   Müller, Anja ^c   Reinicke, Christine ^c   Skrok, Jan ^d   Frericks, Bernd B ^e   Albrecht, Thomas ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^c Carl von Basedow Klinikum Merseburg   (Germany)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DRK KLINIKEN BERLIN WESTEND   (Germany)

Author keywords

colorectal cancer; Gd BOPTA; hepatic transit time; liver; magnetic resonance imaging; metastases

Indexed keywords

GADOBENIC ACID;

AGED; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEPATIC ARTERY; HEPATIC TRANSIT TIME; HUMAN; LIVER; LIVER METASTASIS; LIVER VEIN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE TRANSITION; PORTAL VEIN; PRIORITY JOURNAL; TIME LAPSE IMAGING;

AGED, 80 AND OVER; BLOOD FLOW VELOCITY; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HEPATIC ARTERY; HUMANS; LIVER CIRCULATION; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PULSE WAVE ANALYSIS;

EID: 84869433920     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23772     Document Type: Article

References (29)

1. O'Brien MJ,. Cancer of the colon and rectum: current concepts of aetiology and pathogenesis. Ir J Med Sci 1988; 157 (Suppl): 5-15.
2. Leen E,. The detection of occult liver metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999; 6: 7-15.
3. Finlay IG, McArdle CS,. Occult hepatic metastases in colorectal carcinoma. Br J Surg 1986; 73: 732-735.
4. Kruskal JB, Thomas P, Kane RA, Goldberg SN,. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004; 231: 482-490.
5. Leveson SH, Wiggins PA, Nasiru TA, Giles GR, Robinson PJ, Parkin A,. Improving the detection of hepatic metastases by the use of dynamic flow scintigraphy. Br J Cancer 1983; 47: 719-721.
6. Leveson SH, Wiggins PA, Giles GR, Parkin A, Robinson PJ,. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg 1985; 72: 128-130.
7. Yarmenitis SD, Kalogeropoulou CP, Hatjikondi O, et al. An experimental approach of the Doppler perfusion index of the liver in detecting occult hepatic metastases: histological findings related to the hemodynamic measurements in Wistar rats. Eur Radiol 2000; 10: 417-424.
8. Warren HW, Angerson WJ, Leen E, Carter R, McArdle CS, Cooke TG,. Haemodynamic changes associated with colorectal liver metastases: evidence of a humoral mediator (abstract). Br J Surg 1993; 80: 1461.
9. Cooke DA, Parkin A, Wiggins P, Robinson PJ, Giles GR,. Hepatic perfusion index and the evolution of liver metastases. Nucl Med Commun 1987; 8: 970-972.
10. Perkins AC, Whalley DR, Ballantyne KC, Hardcastle JD,. Reliability of the hepatic perfusion index for the detection of liver metastases. Nucl Med Commun 1987; 8: 982-989.
11. Blomley MJ, Coulden R, Dawson P, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995; 19: 424-433.
12. Miles KA, Hayball MP, Dixon AK,. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188: 405-411.
13. Shi GF, Wang SJ, Wang Q, et al. [Effect of perfusion CT scan on hepatic hemodynamic changes in rats with liver micrometastases]. Ai Zheng 2006; 25: 849-854.
14. Leen E, Goldberg JA, Angerson WJ, McArdle CS,. Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000; 355: 34-37.
15. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002; 47: 135-142.
16. Totman JJ, O'Gorman R L, Kane PA, Karani JB,. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol 2005; 78: 105-109.
17. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cook TG, McArdle CS,. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 1995; 195: 113-116.
18. Leen E, Angerson WG, Cooke TG, McArdle CS,. Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival. Ann Surg 1996; 223: 199-203.
19. Roumen RM, Scheltinga MR, Slooter GD, van der Linden AW,. Doppler perfusion index fails to predict the presence of occult hepatic colorectal metastases. Eur J Surg Oncol 2005; 31: 521-527.
20. Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF,. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001; 74: 752-755.
21. Lim AK, Taylor-Robinson SD, Patel N, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54: 128-133.
22. Bernatik T, Strobel D, Hausler J, Hahn EG, Becker D,. [Hepatic transit time of an ultrasound echo enhancer indicating the presence of liver metastases-first clinical results]. Ultraschall Med 2002; 23: 91-95.
23. Bernatik T, Becker D, Neureiter D, et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004; 16: 313-317.
24. Hohmann J, Muller C, Oldenburg A, et al. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: a prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. Ultrasound Med Biol 2009; 35: 1427-1435.
25. Zhou JH, Li AH, Cao LH, et al. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound. Br J Radiol 2008; 81: 113-119.
26. Cuenod C, Leconte I, Siauve N, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001; 218: 556-561.
27. Wright KC, Ravoori MK, Dixon KA, et al. Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model. Radiology 2011; 260: 718-726.
28. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV,. Hepatobiliary- specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009; 29: 1725-1748.
29. Lim AK, Patel N, Eckersley RJ, et al. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006; 240: 130-135.